Sign In

Investor Relations Home

Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | Financial Tear Sheet Financial Tear Sheet

Welcome to Markel Corporation's (MKL-NYSE) Investor Relations section.

Markel Corporation markets and underwrites specialty insurance products and programs to a variety of niche markets. In each of these markets, we seek to provide quality products and excellent customer service so that we remain a market leader. Our financial goals are to earn consistent underwriting profits and superior investment returns to build shareholder value.

For more information about Markel Corporation, please click here.

Recent NewsMore >>
03/13/18Markel appoints Julia Chu as Chief Global Ceded Reinsurance Officer
RICHMOND, Va., March 13, 2018 /PRNewswire/ -- Markel Corporation (NYSE: MKL) announced today that Julia Chu has been appointed Chief Global Ceded Reinsurance Officer, effective immediately. In this newly created position, Chu will head up Ceded Re functions across Markel's product lines and international insurance operations (71 offices in 21 countries). She will work with executive management to strategically deploy ceded reinsurance in support of Markel's business objectives. ... 
Printer Friendly Version
02/23/18Beth Hungate-Noland to join Markel Ventures
RICHMOND, Va., Feb. 23, 2018 /PRNewswire/ -- Markel Corporation (NYSE: MKL) announced today that Beth Hungate-Noland will join the company as a Managing Director. Hungate-Noland, who has been a Partner at Williams Mullen for the past 15 years, will join the team at Markel that is responsible for the oversight of the company's Markel Ventures operations. "Beth has been a valued partner of the Markel Ventures family for many years and played an integral role wi... 
Printer Friendly Version
02/21/18Markel names Patrick Moylan Managing Director, Medical Product Line
RICHMOND, Va., Feb. 21, 2018 /PRNewswire/ -- Markel Corporation (NYSE: MKL) announced today that Patrick Moylan has been named Managing Director, Medical Product Line. Moylan is responsible for Markel's product development and underwriting efforts in the health care space. Alan Rodrigues, Executive Underwriting Officer, Casualty, stated, "Patrick's extensive insurance industry experience and strong broker relationships are invaluable assets for our team. In h... 
Printer Friendly Version
02/06/18Markel Reports 2017 Financial Results
RICHMOND, Va., Feb. 6, 2018 /PRNewswire/ -- Markel Corporation (NYSE: MKL) reported book value per common share outstanding of $683.55 at December 31, 2017, up 13% from $606.30 at December 31, 2016. Over the five-year period ended December 31, 2017, the compound annual growth in book value per common share outstanding was 11%. Comprehensive income to shareholders was $1.2 billion for the year ended December 31, 2017 compared to $667.0 million in 2016. The combined ratio was 105% in 2017 compared... 
Printer Friendly Version
Upcoming EventsMore >>
There are currently no events scheduled.
MKL (Common Stock)
ExchangeNYSE (US Dollar)
Change (%) Stock is Down 3.86 (0.33%)
Data as of 03/23/18 4:02 p.m. ET
Minimum 20 minute delay
Refresh quote
Featured Report
Download Documentation 2017 Annual Report

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.